scholarly journals Editorial: Quality or quantity? Unraveling the role of Treg cells in rheumatoid arthritis

2013 ◽  
Vol 65 (3) ◽  
pp. 552-554 ◽  
Author(s):  
Berent Prakken ◽  
Ellen Wehrens ◽  
Femke van Wijk
2021 ◽  
Vol 12 ◽  
Author(s):  
Qi Jiang ◽  
Guocan Yang ◽  
Qi Liu ◽  
Shengjun Wang ◽  
Dawei Cui

Rheumatoid arthritis (RA) is a systemic and heterogeneous autoimmune disease with symmetrical polyarthritis as its critical clinical manifestation. The basic cause of autoimmune diseases is the loss of tolerance to self or harmless antigens. The loss or functional deficiency of key immune cells, regulatory T (Treg) cells, has been confirmed in human autoimmune diseases. The pathogenesis of RA is complex, and the dysfunction of Tregs is one of the proposed mechanisms underlying the breakdown of self-tolerance leading to the progression of RA. Treg cells are a vital component of peripheral immune tolerance, and the transcription factor Foxp3 plays a major immunosuppressive role. Clinical treatment for RA mainly utilizes drugs to alleviate the progression of disease and relieve disease activity, and the ideal treatment strategy should be to re-induce self-tolerance before obvious tissue injury. Treg cells are one of the ideal options. This review will introduce the classification, mechanism of action, and characteristics of Treg cells in RA, which provides insights into clinical RA treatment.


2015 ◽  
Vol 74 (Suppl 1) ◽  
pp. A2.2-A2
Author(s):  
M Massalska ◽  
E Kuca-Warnawin ◽  
A Radzikowska ◽  
U Musialowicz ◽  
U Skalska ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-12 ◽  
Author(s):  
Alessia Alunno ◽  
Mirko Manetti ◽  
Sara Caterbi ◽  
Lidia Ibba-Manneschi ◽  
Onelia Bistoni ◽  
...  

In recent years several studies investigated the role of T lymphocyte subpopulations in the pathogenesis of rheumatoid arthritis (RA). Pathogenic Th17 cells mediate pannus growth, osteoclastogenesis, and synovial neoangiogenesis; hence they are key players in the development of the disease. On the other hand, regulatory T (Treg) cells are a T cell subset whose peculiar function is to suppress autoreactive lymphocytes. The imbalance between Th17 and Treg cells has been identified as a crucial event in the pathogenesis of RA. In addition, the effects of currently employed RA therapeutic strategies on these lymphocyte subpopulations have been extensively investigated. This review article aims to discuss current knowledge on Treg and Th17 cells in RA and possible implications of their therapeutic targeting in this disorder.


Author(s):  
Yuya Takakubo ◽  
G. Barreto ◽  
Yrjo T. Konttinen ◽  
H. Oki ◽  
Michiaki Takagi

2018 ◽  
Vol 16 (7(part 2)) ◽  
pp. 99-101
Author(s):  
L. I. Feiskhanova ◽  
◽  
I. Kh. Valeeva ◽  
A. K. Feiskhanov ◽  
◽  
...  

Sign in / Sign up

Export Citation Format

Share Document